Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. mader_mary@lilly.com
Abstract:
The anti-proliferative activity of acylated heterocyclic sulfonamides is described in Vascular Endothelial Growth Factor-dependent Human Umbilical Vascular Endothelial Cells (VEGF-HUVEC) and in HCT116 tumor cells in a soft agar diffusion assay.